Tuesday, Apr 21, 2026
English News
  • Hyderabad
  • Telangana
  • AP News
  • India
  • World
  • Entertainment
  • Sport
  • Science and Tech
  • Business
  • Rewind
  • ...
    • NRI
    • View Point
    • cartoon
    • My Space
    • Education Today
    • Reviews
    • Property
    • Lifestyle
E-Paper
  • NRI
  • View Point
  • cartoon
  • My Space
  • Reviews
  • Education Today
  • Property
  • Lifestyle
Home | Business | Expert Panel Permits Dr Reddys To Submit Sputnik Light Russian Phase Iii Data In India

Expert panel permits Dr Reddy’s to submit Sputnik Light Russian phase III data in India

On Wednesday, the Subject Expert Committee (SEC) deliberated on the submission for Marketing Authorisation of Sputnik Light in India from Dr Reddy’s

By Telangana Today
Updated On - 1 July 2021, 10:48 PM
Expert panel permits Dr Reddy’s to submit Sputnik Light Russian phase III data in India
Sputnik Light is a single dose Covid-19 vaccine from the makers of Sputnik V.
whatsapp facebook twitter telegram

Hyderabad: Hyderabad-based pharmaceuticals company Dr Reddy’s Laboratories on Thursday said that the single-dose Sputnik Light vaccine can submit Russian safety data for approval in India. Sputnik Light is a single dose Covid-19 vaccine from the makers of Sputnik V and is yet to be approved in the country.

On Wednesday, the Subject Expert Committee (SEC) deliberated on the submission for Marketing Authorisation of Sputnik Light in India from Dr Reddy’s. The company presented to the SEC, interim safety and efficacy data from the phase I / II clinical trial of Sputnik Light in Russia, along with a clinical trial protocol for a phase III trial of Sputnik Light in India.


In view of the fact that Sputnik Light is the first dose component of Sputnik V, and Dr Reddy’s has already generated safety and immunogenicity data on the first dose component in India through its clinical trial and; a phase III efficacy trial is currently underway in Russia on Sputnik Light, the SEC recommended that Dr Reddy’s should submit safety, immunogenicity and efficacy data from the phase III clinical trial of Sputnik Light in Russia to the SEC for its consideration of Marketing Authorisation of Sputnik Light in India.

“Further, the SEC also observed that in view of the safety and immunogenicity data already generated by Dr Reddy’s in India on the first dose component of Sputnik V (in other words, Sputnik Light), there was no need for a separate phase III trial of Sputnik Light in India,” Dr Reddy’s said in a statement.

The company’s clarification comes amid reports of SEC denying permission to Dr Reddy’s for conducting phase 3 trials of Russia’s Covid-19 vaccine Sputnik Light in India.


Now you can get handpicked stories from Telangana Today on Telegram everyday. Click the link to subscribe.

Click to follow Telangana Today Facebook page and Twitter .


 

  • Follow Us :
  • Tags
  • Covid-19
  • COVID-19 vaccine
  • Dr.Reddy's
  • Sputnik Light

Related News

  • Dandari-Gussadi dance troupes in Adilabad await financial aid from government

    Dandari-Gussadi dance troupes in Adilabad await financial aid from government

  • Dr Reddy’s Q2 profit rises 14 per cent to Rs 1,437 crore

    Dr Reddy’s Q2 profit rises 14 per cent to Rs 1,437 crore

  • KTR, Harish attack Revanth over failed promises; pitch for return of KCR as CM

    KTR, Harish attack Revanth over failed promises; pitch for return of KCR as CM

  • Study finds Covid protein may trigger immune system to attack healthy cells; New variant spreads globally

    Study finds Covid protein may trigger immune system to attack healthy cells; New variant spreads globally

Latest News

  • Master cook courses in demand as youth eye food business

    4 mins ago
  • India-Canada trade talks gain importance amid new world order

    7 mins ago
  • Bombay HC slams Centre over delay in Agniveer benefits case

    14 mins ago
  • India should aim to achieve 100 pc ethanol blending: Nitin Gadkari

    18 mins ago
  • UKIBC, T-Works sign MoU to boost UK-India tech, manufacturing ties

    19 mins ago
  • PIL in HC alleges cruelty against bovines in cattle markets in Kerala

    23 mins ago
  • MANAGE Hyderabad launches ‘The Far Acre’ on agri-entrepreneurs

    26 mins ago
  • India to launch expanded Semiconductor Mission 2.0 with Rs 1.2 lakh crore push: Report

    28 mins ago

company

  • Home
  • About Us
  • Contact Us
  • Privacy Policy

business

  • Subscribe

telangana today

  • Telangana
  • Hyderabad
  • Latest News
  • Entertainment
  • World
  • Andhra Pradesh
  • Science & Tech
  • Sport

follow us

  • Telangana Today Telangana Today
Telangana Today Telangana Today

© Copyrights 2024 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam

.